AstraZeneca

In News

ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer - Fierce Pharma

Fierce Pharma - Jun 01, 2026

ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do - Proactive financial news

Proactive financial news - Jun 01, 2026

AstraZeneca Scores In Liver Cancer On Its Path To $40 Billion In Oncology Sales - Investor's Business Daily

Investor's Business Daily - Jun 01, 2026

AstraZeneca's triplet combo succeeds in some liver cancer patients - Endpoints News

Endpoints News - Jun 01, 2026

AstraZeneca falls Monday, underperforms market - MarketWatch

MarketWatch - Jun 01, 2026

FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy - Pharmaceutical Technology

Pharmaceutical Technology - Jun 01, 2026

ASCO26: AstraZeneca’s AZD-3470 demonstrates PRMT5 inhibitor safety for cHL patients - Clinical Trials Arena

Clinical Trials Arena - Jun 01, 2026

AstraZeneca reports ‘further positive results’ from Phase 3 SERENA-6 trial - TipRanks

TipRanks - Jun 02, 2026

AstraZeneca's blood pressure drug wins U.S. approval - Reuters

Reuters - May 17, 2026

Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. - AstraZeneca

AstraZeneca - May 28, 2026

ASCO26: AstraZeneca unveils data it hopes will persuade FDA to approve oral SERD - FirstWord Pharma

FirstWord Pharma - Jun 02, 2026

AstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica Money - Britannica

Britannica - May 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment